TY - JOUR
T1 - Longitudinal assessment of thyroid function in pregnancy
AU - Ekinci, Elif I.
AU - Lu, Zhong X.
AU - Sikaris, Ken
AU - Bittar, Intissar
AU - Cheong, Karey Y.
AU - Lam, Que
AU - Crinis, Nick
AU - Houlihan, Christine A.
PY - 2013
Y1 - 2013
N2 - Background: Trimester-specific reference intervals (RIs) for thyroid function tests are lacking for Beckman Dxl 800 analysers. We aimed to establish RIs for thyroid stimulating hormone (TSH), free thyroxine (fT4) and to track intraindividual changes in thyroid function throughout pregnancy. Methods: One hundred and thirty healthy women without antithyroid peroxidase antibodies were followed longitudinally. Thyroid function was determined at trimester-1 (T1): 9-13 weeks; trimester-2 (T2): 22-26 weeks; trimester-3 (T3): 35-39 weeks and postpartum (PP): 8-12 weeks. A subgroup (n 1/4 47) was used to track intraindividual changes using PP as non-pregnant state (baseline). Results: For trimesters 1-3, TSH (median (2.5th, 5th, 95th and 97.5th percentile)) was 0.77 (0.03, 0.05, 2.33, 3.05), 1.17 (0.42, 0.47, 2.71, 3.36) and 1.35 (0.34, 0.42, 2.65, 2.83) mIU/L, respectively. Free T4 (mean (95%CI)) was 10.7 (5.9-15.5), 8.1 (4.9-11.3), 7.8 (4.5-11.0) pmol/L, respectively. In T2 and T3, 36% and 41% of the fT4 values, respectively, fell below the non-pregnancy lower normal limit. In the subgroup assessed for longitudinal changes, of the women with baseline TSH 4 median, 71-75% remained at or below the corresponding median for trimesters 1-3. Of the women with baseline fT4 4 median, 69-81% also remained at or below the corresponding median for trimesters 1-3. High correlation was observed at different trimesters and baseline for TSH (Spearman's r: 0.593-0.846, P < 0.001) and for fT4 (r: 0.480-0.739, P< 0.001). Conclusions: Use of trimester-specific RIs would prevent misclassification of thyroid function during pregnancy. In the majority of women, TSH and fT4 tracked on the same side of the median distribution, from a non-pregnant baseline, throughout pregnancy.
AB - Background: Trimester-specific reference intervals (RIs) for thyroid function tests are lacking for Beckman Dxl 800 analysers. We aimed to establish RIs for thyroid stimulating hormone (TSH), free thyroxine (fT4) and to track intraindividual changes in thyroid function throughout pregnancy. Methods: One hundred and thirty healthy women without antithyroid peroxidase antibodies were followed longitudinally. Thyroid function was determined at trimester-1 (T1): 9-13 weeks; trimester-2 (T2): 22-26 weeks; trimester-3 (T3): 35-39 weeks and postpartum (PP): 8-12 weeks. A subgroup (n 1/4 47) was used to track intraindividual changes using PP as non-pregnant state (baseline). Results: For trimesters 1-3, TSH (median (2.5th, 5th, 95th and 97.5th percentile)) was 0.77 (0.03, 0.05, 2.33, 3.05), 1.17 (0.42, 0.47, 2.71, 3.36) and 1.35 (0.34, 0.42, 2.65, 2.83) mIU/L, respectively. Free T4 (mean (95%CI)) was 10.7 (5.9-15.5), 8.1 (4.9-11.3), 7.8 (4.5-11.0) pmol/L, respectively. In T2 and T3, 36% and 41% of the fT4 values, respectively, fell below the non-pregnancy lower normal limit. In the subgroup assessed for longitudinal changes, of the women with baseline TSH 4 median, 71-75% remained at or below the corresponding median for trimesters 1-3. Of the women with baseline fT4 4 median, 69-81% also remained at or below the corresponding median for trimesters 1-3. High correlation was observed at different trimesters and baseline for TSH (Spearman's r: 0.593-0.846, P < 0.001) and for fT4 (r: 0.480-0.739, P< 0.001). Conclusions: Use of trimester-specific RIs would prevent misclassification of thyroid function during pregnancy. In the majority of women, TSH and fT4 tracked on the same side of the median distribution, from a non-pregnant baseline, throughout pregnancy.
KW - Beckman Dxl 800 analyser
KW - Free T3
KW - Free T4
KW - Pregnancy
KW - Thyroid function
KW - Thyroid stimulating hormone
KW - Trimester-specific reference intervals
UR - http://www.scopus.com/inward/record.url?scp=84899562602&partnerID=8YFLogxK
U2 - 10.1177/0004563213486450
DO - 10.1177/0004563213486450
M3 - Article
C2 - 23873872
SN - 0004-5632
VL - 50
SP - 595
EP - 602
JO - Annals of Clinical Biochemistry
JF - Annals of Clinical Biochemistry
IS - 6
ER -